NCT01973881Recruiting
Quantitative MRI for Myelofibrosis
Quantitative MRI for Myelofibrosis - MRI Parameters as Biomarkers for Analyzing Extent of Disease and Measuring Response to Treatment
Source: ClinicalTrials.gov · Last updated 31 Jul 2026
Brief summary (registry, in English)
This study is for the development and validation of functional magnetic resonance imaging (MRI) parameters as biomarkers for analyzing extent of disease and quantifying response to treatment in patients with myelofibrosis.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 192 (estimated)
- First submitted
- 25 Oct 2013
- Start date
- 22 Dec 2014
- Primary completion date
- Dec 2026
- Lead sponsor
- University of Michigan Rogel Cancer Center
- Diseases
- Myeloproliferative neoplasms
- NCT number
- NCT01973881
What you commit to
- Study type: Observational
- Planned participants: 192
- From 22 Dec 2014 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Any prior adverse event associated with MRI that is not related to injection of contrast agents or other medicines.
- \-
Other
- Patients with pacemakers or other implanted magnetic devices that may malfunction or move because of the strong magnetic field inside the MRI room and scanner.
Who the study is looking for
- Male /female subjects over the age of 18
- Diagnosis of primary myelofibrosis, post-polycythemia vera myelofibrosis, or post-essential thrombocythemia myelofibrosis.
- No contraindications to MRI
- Able to undergo MRI without anesthesia
- \-
Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Michigan Hospital Coordinator of this site? Confirm its status | Ann Arbor | United States | Recruiting |
Related publications
- Quantitative MRI Assessment of Bone Marrow Disease in Myelofibrosis: A Prospective Study.Radiol Imaging Cancer · 2025 · PMID 41236389
This page is information, not medical advice. Discuss any trial with your doctor.